Pfizer Inc Cdr Stock Today
| PFE Stock | 11.94 0.26 2.23% |
Performance0 of 100
| Odds Of DistressLess than 19
|
Pfizer is selling at 11.94 as of the 24th of November 2024; that is 2.23% increase since the beginning of the trading day. The stock's open price was 11.68. Pfizer has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Pfizer Inc CDR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of January 2023 and ending today, the 24th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Pfizer is entity of Canada. It is traded as Stock on NEO exchange. The company has 16.69 B outstanding shares. More on Pfizer Inc CDR
Moving against Pfizer Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Pfizer Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pfizer's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pfizer or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman CEO | Albert DVM | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-General, Healthcare (View all Sectors) | ||||
Pfizer's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Pfizer's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsPfizer can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Pfizer's financial leverage. It provides some insight into what part of Pfizer's total assets is financed by creditors.
| |||||
Pfizer Inc CDR (PFE) is traded on NEO Exchange in Canada and employs 88,000 people. Pfizer is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 199.25 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pfizer Inc CDR operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 16.69 B outstanding shares.
Pfizer generates positive cash flow from operations, but has no cash available
Check Pfizer Probability Of Bankruptcy
Pfizer Inc CDR Risk Profiles
Although Pfizer's alpha and beta are two of the key measurements used to evaluate Pfizer's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.967 | |||
| Standard Deviation | 1.35 | |||
| Variance | 1.82 | |||
| Risk Adjusted Performance | (0.09) |
Pfizer Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pfizer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Pfizer Corporate Management
Elected by the shareholders, the Pfizer's board of directors comprises two types of representatives: Pfizer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pfizer. The board's role is to monitor Pfizer's management team and ensure that shareholders' interests are well served. Pfizer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pfizer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Young | Advisor | Profile | |
| Jennifer Damico | Controller VP | Profile | |
| Aamir Malik | Executive Officer | Profile | |
| DVM DVM | Chairman CEO | Profile | |
| Frank DAmelio | CFO VP | Profile | |
| Douglas Lankler | Executive Counsel | Profile | |
| Rady Johnson | Quality Compliance | Profile |
Other Information on Investing in Pfizer Stock
Pfizer financial ratios help investors to determine whether Pfizer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pfizer with respect to the benefits of owning Pfizer security.